Brian McIntosh

Director of Scientific Experts and Global Lead for Preclinical Cell & Gene Therapy at Labcorp Drug Development

Brian McIntosh is a highly experienced professional in the field of drug and therapeutic research, currently serving as the Director of Scientific Experts and Global Lead for Preclinical Cell & Gene Therapy at Labcorp Drug Development.1 His career spans over 25 years in both industry and academia, with specialized expertise in several key areas.3

Professional Experience

At Labcorp Drug Development, McIntosh has been in his current role since July 2015.1 His responsibilities include:

Leading the Cell and Gene Therapy (CGT)/Advanced Therapy Medicinal Product (ATMP) service line within Labcorp's preclinical business
Heading a team of preclinical safety experts in the Early Development business
Serving as a subject matter expert and Scientific Advisor for safety assessment studies in CGT/ATMP
Contributing to the Labcorp CGT Steering Committee

Prior to his current position, McIntosh held several other roles, including:

Consultant at AMGEN's BioAssay Technology Group (2012-2015)
Assistant Scientist and Head of Automation and Screening at The Morgridge Institute for Research (2011-2015)
Post Doctoral Researcher at the University of Wisconsin-Madison (2009-2011)

Education and Expertise

McIntosh holds a Ph.D. from the University of Wisconsin-Madison, which he obtained between 2003 and 2009.1 His areas of expertise include:

Cancer biology
Immunology
Genetic engineering
Toxicology
Developmental stem cell biology
IND-enabling support for cell and gene therapies3

Contributions to the Field

Throughout his career, McIntosh has made significant contributions to the field of cell and gene therapy:

He has been involved in developing seminars and arranging symposium presentations on scientific subjects related to therapeutic development.1
McIntosh has played a key role in expanding Labcorp's CGT/ATMP preclinical safety assessment offerings.1
He has authored numerous scientific publications, with his work being cited hundreds of times.2

Brian McIntosh's extensive experience and leadership in the field of cell and gene therapy make him a valuable asset in advancing the development of innovative therapeutic approaches.